Sarda Proteins Ltd (BOM:519242)

Sarda Proteins Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	161.58	241.91	12.96	57.95	107.6
Other Revenue	-	0	-	-	-
Revenue	161.58	241.91	12.96	57.95	107.6
Revenue Growth (YoY)	-33.20%	1766.88%	-77.64%	-46.14%	-5.28%
Cost of Revenue	154.78	239.11	12.07	57.18	102.86
Gross Profit	6.8	2.8	0.89	0.77	4.73
Selling, General & Admin	0.3	1	1.59	1.48	1.39
Other Operating Expenses	3.6	1.61	0.76	0.77	0.64
Operating Expenses	3.91	2.61	2.35	2.24	2.03
Operating Income	2.9	0.2	-1.46	-1.47	2.7
Interest Expense	-	-	-0	-	-0
Interest & Investment Income	-	0.01	1.65	1.6	0.85
Other Non Operating Income (Expenses)	3.48	0	0	-	-
EBT Excluding Unusual Items	6.38	0.2	0.19	0.13	3.55
Other Unusual Items	-	-	-	-	-0.02
Pretax Income	6.38	0.2	0.19	0.13	3.53
Income Tax Expense	-	0.15	-0.01	0.46	0.45
Net Income	6.38	0.05	0.19	-0.33	3.07
Net Income to Common	6.38	0.05	0.19	-0.33	3.07
Net Income Growth	12407.84%	-73.71%	-	-	-
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
Shares Change (YoY)	-0.11%	-	-	-	-
EPS (Basic)	3.70	0.03	0.11	-0.19	1.78
EPS (Diluted)	3.70	0.03	0.11	-0.19	1.78
EPS Growth	12421.57%	-73.14%	-	-	-
Free Cash Flow	-763.89	-1.11	-2.31	-3.01	1.04
Free Cash Flow Per Share	-443.07	-0.64	-1.34	-1.75	0.60
Gross Margin	4.21%	1.16%	6.84%	1.34%	4.40%
Operating Margin	1.79%	0.08%	-11.30%	-2.54%	2.51%
Profit Margin	3.95%	0.02%	1.50%	-0.57%	2.86%
Free Cash Flow Margin	-472.75%	-0.46%	-17.82%	-5.20%	0.97%
EBITDA	2.9	-	-	-1.46	2.7
EBITDA Margin	1.80%	-	-	-2.53%	2.51%
D&A For EBITDA	0.01	-	-	0	0
EBIT	2.9	0.2	-1.46	-1.47	2.7
EBIT Margin	1.79%	0.08%	-11.30%	-2.53%	2.51%
Effective Tax Rate	-	74.75%	-	355.43%	12.86%
Revenue as Reported	165.07	241.92	14.61	59.55	108.45
Advertising Expenses	-	0.06	0.07	0.07	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.